Efficacy and Safety of Racecadotril in the Treatment of Children Aged 3 to 60 Months Suffering From Acute Diarrhea: A Controlled Randomized, Open-label, Parallel-group Study
Phase of Trial: Phase III
Latest Information Update: 05 Oct 2018
At a glance
- Drugs Racecadotril (Primary)
- Indications Diarrhoea
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 26 Sep 2018 Status changed from not yet recruiting to recruiting.
- 12 Jun 2018 Planned initiation date changed from 10 Apr 2018 to 30 Jun 2018.
- 27 Mar 2018 New trial record